ICON Public Limited Company
ICLR
Rang in aandelen
#1603
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Aandeelprijs
$174.32
Laatst gesynchroniseerd: 2026-10-20
Marktkapitalisatie
$13.45B
Verandering (1 dag)
3.68%
Verandering (1 jaar)
-9.80%
Land
IE
Handel ICON Public Limited Company (ICLR)
Categorie
Healthcare
Omzet van ICON Public Limited Company (ICLR)
Omzet in Jun 2026 TTM: $8.25B
Volgens de laatste financiële rapporten van ICON Public Limited Company bedraagt de huidige omzet van het bedrijf (TTM) $8.25B. In 2023 behaalde het bedrijf een omzet van $8.12B een stijging ten opzichte van de omzet in het jaar 2022, die $7.74B bedroeg. De omzet is het totale bedrag aan inkomsten dat een bedrijf genereert door de verkoop van goederen of diensten. In tegenstelling tot de winst worden er geen kosten afgetrokken.
Omzetgeschiedenis van ICON Public Limited Company van 2001 tot 2026
Omzet aan het einde van elk jaar
| Jaar | Omzet | Wijzigen |
|---|---|---|
| 2026 (TTM) | $8.25B | -0.35% |
| 2024 | $8.28B | 1.99% |
| 2023 | $8.12B | 4.89% |
| 2022 | $7.74B | 41.24% |
| 2021 | $5.48B | 95.93% |
| 2020 | $2.80B | -0.30% |
| 2019 | $2.81B | 8.09% |
| 2018 | $2.60B | 47.62% |
| 2017 | $1.76B | 5.52% |
| 2016 | $1.67B | 5.81% |
| 2015 | $1.57B | 4.77% |
| 2014 | $1.50B | 12.52% |
| 2013 | $1.34B | 19.83% |
| 2012 | $1.12B | 17.90% |
| 2011 | $945.73M | 5.08% |
| 2010 | $900.04M | 1.40% |
| 2009 | $887.61M | 2.58% |
| 2008 | $865.25M | 37.18% |
| 2007 | $630.72M | 38.44% |
| 2006 | $455.60M | 31.60% |
| 2005 | $346.20M | 16.60% |
| 2004 | $296.92M | 31.54% |
| 2003 | $225.73M | 44.18% |
| 2002 | $156.56M | 34.77% |
| 2001 | $116.16M | 0.00% |
Omzet van vergelijkbare bedrijven of concurrenten
| Bedrijf | Omzet | Omzetverschil | Land |
|---|---|---|---|
| $46.34B | 461.46% |
US
|
|
| $25.11B | 204.22% |
US
|
|
| $2.71B | -67.20% |
US
|
|
| - | - |
CN
|
|
| $7.37B | -10.67% |
US
|
